SCHEMBL9515522

SCHEMBL9515522

O=CCCC(c1ccc(F)cc1F)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
HDAC6 Q9UBN7 5/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SCN9A Q15858 3/20 0.34
P4HTM Q9NXG6 2/20 0.34
SCN5A Q14524 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
HDAC3 O15379 4/20 0.32
HDAC1 Q13547 4/20 0.32
HDAC2 Q92769 4/20 0.32
HDAC4 P56524 3/20 0.32
HDAC7 Q8WUI4 3/20 0.32
HDAC10 Q969S8 3/20 0.32
HDAC11 Q96DB2 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517183 0.90 LMNA (0.38) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9518012 0.86 MEN1 (0.37) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9515545 0.85 HDAC6 (0.36) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9515835 0.84 LMNA (0.39) LMNAPOLBHDAC6NPC1RAB9A
SCHEMBL9519311 0.81 P4HTM (0.36) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9515435 0.80 P4HTM (0.40) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL9515891 0.79 EGFR (0.41) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9515632 0.78 MEN1 (0.38) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9515967 0.78 HIF1A (0.38) HDAC6NPC1RAB9AMEN1KMT2A
SCHEMBL9517189 0.78 LMNA (0.39) LMNAPOLBHDAC6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed